OPKO Health Inc. (NASDAQ:OPK) saw an upside of 1.63% to close Monday at $3.75 after adding $0.06 on the day. The 5-day average trading volume is 1,953,500 shares of the company’s common stock. It has gained $3.80 in the past week. An average of 2,807,390 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 3,014,338.
OPK’s 1-month performance is 5.34% or $0.19 on its low of $3.44 reached on 09/14/21. The company’s shares have touched a 52-week low of $3.02 and high of $6.27, with the stock’s rally to the 52-week high happening on 01/27/21. YTD, OPK has lost -5.06% or -$0.20. However, the current price is down -40.19%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
The company’s PE ratio for the last five years has touched a high of 119.80 and a low of 17.53. OPK stock has a beta of 1.74. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.36 while the price-to-book (PB) in the most recent quarter is 1.39, with the price to cash flow ratio at 35.37.
OPKO Health Inc.’s quick ratio for the period ended June 29 was 1.40, with the current ratio over the same period at 1.80 meaning that OPK stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.11, while the total debt to equity was 0.12. In terms of profitability, the gross margin trailing 12 months is 34.70%. The trailing 12-month EBITDA margin is 9.69% while for the period ending June 29; OPKO Health Inc.’s operating margin was 6.00%. The firm’s gross profit as reported stood at $541.0 million against revenue of $1.44 billion.
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected OPK to announce $0.02 per share in earnings in its latest quarter, but it posted -$0.03, representing a -250.00% surprise. EBITDA for the quarter stood at more than $26.34 million. OPK stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 679.07 million, with total debt at $250.48 million. Shareholders hold equity totaling $681.16 million
Let’s look briefly at OPKO Health Inc. (OPK) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 11 October was 55.29% to suggest the stock is trending Neutral, with historical volatility in this time period at 26.16%.
The stock’s 5-day moving average is $3.70, reflecting a +6.53% or $0.23 change from its current price. OPK is currently trading +4.75% above its 20-day SMA, +4.17% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by +9.01% and -11.87% respectively.
Stochastic %K and %D was 57.72% and 50.48% and the average true range (ATR) pointed at 0.13. The RSI (14) points at 52.67%, while the 14-day stochastic is at 63.41% with the period’s ATR at 0.14. The stock’s 9-day MACD Oscillator is pointing at 0.07 and 0.03 on the 14-day charts.
In the most recent analyst report for OPKO Health Inc. (NASDAQ: OPK), Ladenburg Thalmann launched coverage with a Buy rating. Analysts offering their rating for OPK stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate OPK as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 5 have offered a “buy” rating.
What is OPK’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $5.00 and a high of $8.50, with their median price target at $6.50. Looking at these predictions, the average price target given by analysts is for OPKO Health Inc. (OPK) stock is $6.60.